【レポートの概要(一部)】
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Overview of cancer immunotherapies
• Epidemiology
• Spending on cancer
• Cost of cancer treatment
• Reimbursement policies
• Economic burden of cancer
• Orphan drug designation and regulatory approvals
PART 06: Pipeline portfolio
• Anticipated number of products with single and multi-indications by 2020
PART 07: Market landscape
• Market overview
• Market size and forecast
• Five forces analysis
PART 08: Market segmentation by type
• Cancer monoclonal antibodies
• Clinical trials of cancer monoclonal antibodies
• Immune checkpoint inhibitors
• Cancer vaccines
• Non-specific immunotherapies
• Global cancer monoclonal antibodies market
• Global cancer vaccines market
• Global immune checkpoint inhibitors market
• Global non-specific immunotherapies market
PART 09: Geographical segmentation
• Global cancer immunotherapies market by geography 2015-2020
• Cancer immunotherapies market in Americas
• Cancer immunotherapies market in EMEA
• Cancer immunotherapies market in APAC
PART 10: Market drivers
• Increase in prevalence of cancers
• Increase in demand for cancer monoclonal antibodies
• Patient assistance programs
• Promising pipeline
PART 11: Impact of drivers
PART 12: Market challenges
• Patent expiry of top-selling drugs
• Poor diagnosis and screening
• High developmental costs
• Risk of side-effects
• Stringent regulations
PART 13: Impact of drivers and challenges
PART 14: Market trends
• Increase in cancer awareness
• Emergence of targeted and combination therapies
• Emergence of biosimilars
• Strategic alliances
PART 15: Vendor landscape
• Competitive scenario
• Market share analysis 2015
• Amgen
• Bristol-Myers Squibb
• F. Hoffmann-La Roche
• GlaxoSmithKline
• Merck
• Takeda Pharmaceuticals1
• Other prominent vendors
PART 16: Appendix
• List of abbreviations
PART 17: Explore Technavio
[List of Exhibits]
Exhibit 01: Product offerings
Exhibit 02: Cancer immunotherapies in global cancer drugs market
Exhibit 03: Global incidence of cancer by type 2015
Exhibit 04: Global mortality by cancer type 2015
Exhibit 05: Estimated numbers of male and female cancer survivors by age in US 2014
Exhibit 06: Spending on cancer by distribution channels 2013
Exhibit 07: Annual treatment cost per patient for cancer immunotherapies 2014
Exhibit 08: Average cost of surgeries associated with cancer ($ millions) 2014
Exhibit 09: National reimbursement of cancer drugs by countries 2014
Exhibit 10: US FDA Orphan drug designations and approvals for cancer immunotherapies
Exhibit 11: EU orphan drug designations and approvals for cancer immunotherapies
Exhibit 12: Key events in cancer immunotherapies, discovery, and approvals
Exhibit 13: Timeline of some cancer immunotherapies
Exhibit 14: Phase III pipeline molecules for global cancer monoclonal antibodies market
Exhibit 15: Phase II pipeline molecules for global cancer monoclonal antibodies market
Exhibit 16: Phase I pipeline molecules for global cancer monoclonal antibodies market
Exhibit 17: Pipeline molecules for global immune checkpoint inhibitors market
Exhibit 18: Phase III pipeline molecules for global cancer vaccines market
Exhibit 19: Near-launch immuno-oncology pipeline assets
Exhibit 20: Global cancer immunotherapies market 2015-2020 ($ billions)
Exhibit 21: Factors influencing global cancer immunotherapies market
Exhibit 22: Five forces analysis
Exhibit 23: Global cancer immunotherapies market by type 2015
Exhibit 24: Timeline for approvals of cancer monoclonal antibodies by US FDA
Exhibit 25: Clinical trials of cancer monoclonal antibodies by development phase
Exhibit 26: Status of clinical trials of cancer monoclonal antibodies
Exhibit 27: Global cancer immunotherapies market by type of cancer immunotherapies 2015
Exhibit 28: Global cancer immunotherapies market by type of cancer immunotherapies 2015-2020 ($ billions)
Exhibit 29: Global cancer monoclonal antibodies market 2015-2020 ($ billions)
Exhibit 30: Key drivers and challenges of global cancer monoclonal antibodies market
Exhibit 31: Global cancer vaccines market 2015-2020 ($ billions)
Exhibit 32: Global cancer vaccines market by application 2015
Exhibit 33: Key drivers and challenges of global cancer vaccines market
Exhibit 34: Global immune checkpoint inhibitors market 2015-2020 ($ billions)
Exhibit 35: Key drivers and challenges for global immune checkpoint inhibitors market
Exhibit 36: Global non-specific immunotherapies market 2015-2020 ($ billions)
Exhibit 37: Global cancer immunotherapies market by geography 2015
Exhibit 38: Global cancer immunotherapies market revenue by geography 2015-2020 ($ billions)
Exhibit 39: Cancer immunotherapies market in Americas 2015-2020 ($ billions)
Exhibit 40: Cancer immunotherapies market in EMEA 2015-2020 ($ billions)
Exhibit 41: Cancer immunotherapies market in APAC 2015-2020 ($ billions)
Exhibit 42: Global incidence of cancer 2015 and 2020 in millions
Exhibit 43: Impact of drivers
Exhibit 44: Patent expiries of major cancer monoclonal antibodies by 2020
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Expected combination regimen launches in oncology
Exhibit 47: Top cancer immunotherapies based on sales 2014 ($ billions)
Exhibit 48: YoY Sales comparison of top drugs 2011-2014 ($ billions)
Exhibit 49: Cancer immunotherapy companies by origin country
Exhibit 50: Amgen: YoY growth and revenue generated from net product sales of Xgeva 2011-2014 ($ millions)
Exhibit 51: Amgen: YoY growth and revenue generated from net product sales of Prolia 2011-2014 ($ millions)
Exhibit 52: Amgen: YoY growth and revenue generated from net product sales of Vectibix worldwide excluding Japan 2011-2014 ($ millions)
Exhibit 53: Amgen: YoY growth and revenue of Vectibix in US 2012-2014 ($ millions)
Exhibit 54: Amgen: YoY growth and revenue of Vectibix in ROW 2012-2014 ($ millions)
Exhibit 55: Amgen: Key takeaways
Exhibit 56: Bristol-Myers Squibb: Segmentation by revenue 2014
Exhibit 57: Bristol-Myers Squibb: Revenue of oncology products by category 2014
Exhibit 58: Bristol-Myers Squibb: YoY growth and revenue generated from net product sales of Yervoy 2011-2014 ($ millions)
Exhibit 59: Bristol-Myers Squibb: YoY growth and revenue of Erbitux in US, Canada, and Japan 2010-2014 ($ millions)
Exhibit 60: Bristol-Myers Squibb: Key takeaways
Exhibit 61: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of MabThera/Rituxan 2011-2014 ($ billions)
Exhibit 62: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Avastin 2011-2014 ($ billions)
Exhibit 63: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Herceptin 2011-2014 ($ billions)
Exhibit 64: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in US 2013-2014 ($ billions)
Exhibit 65: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in EU 2013-2014 ($ billions)
Exhibit 66: F. Hoffmann-La Roche: YoY growth and revenue of Herceptin in Japan 2013-2014 ($ millions)
Exhibit 67: F. Hoffmann-La Roche: YoY growth and revenue generated from net product sales of Perjeta 2012-2014 ($ millions)
Exhibit 68: F. Hoffmann-La Roche: Revenue generated from net product sales of Kadcyla 2013-2014 ($ millions)
Exhibit 69: F. Hoffmann-La Roche: Key takeaways
Exhibit 70: GlaxoSmithKline: YOY growth and revenue of Arzerra 2012-2014 ($ millions)3
Exhibit 71: GlaxoSmithKline: YOY growth and revenue of Cervarix 2012-2014 ($ millions)3
Exhibit 72: GlaxoSmithKline: Key takeaways
Exhibit 73: Merck: YoY growth and revenue of Gardasil 2012-2014 ($ billions)6
Exhibit 74: Merck: YoY growth and revenue generated from net product sales of Erbitux, excluding US, Canada, and Japan 2011-2014 ($ billions
Exhibit 75: Merck: YOY growth and revenue of Erbitux in Europe 2012-2014 ($ millions)
Exhibit 76: Merck: YOY growth and revenue of Erbitux in emerging markets 2012-2014 ($ millions)
Exhibit 77: Merck: YOY growth and revenue of Erbitux in ROW 2012-2014 ($ millions)
Exhibit 78: Merck: Region-wise revenues of Erbitux 2012-2014 ($ millions)
Exhibit 79: Merck: Key takeaways
Exhibit 80: Takeda Pharmaceuticals: YoY growth and revenue generated from net product sales of Adcetris ($ millions)
Exhibit 81: Takeda Pharmaceuticals: YoY growth and revenue of Vectibix in Japan ($ millions)
Exhibit 82: Takeda Pharmaceuticals: Key takeaways
【レポート販売概要】
■ タイトル:がん免疫療法の世界市場:モノクローナル抗体、免疫チェックポイント阻害薬、がんワクチン■ 英文:Global Cancer Immunotherapies Market 2016-2020
■ 発行日:2016年4月27日
■ 調査会社:Technavio
■ 商品コード:IRTNTR8400
■ 調査対象地域:グローバル
- たんぱく質成分のの世界市場予測(~2022):動物性たんぱく質、植物性たんぱく質The protein ingredients market is projected to reach USD 58.49 Billion by 2022, at a CAGR of 6.0% from 2017, in terms of value. In terms of volume, the market is projected to reach 8,713.7 KT by 2022, at a CAGR of 4.9% from 2017. The protein ingredients market is growing in accordance with the advancement of the nutritional food & beverage industry. The rise in demand for protein ingredients from …
- 医療保険取引所(HIX)の世界市場:タイプ別(民間、公的)、コンポーネント別(ハードウェア、ソフトウェア、サービス)、段階別(実装、QA、運用)、最終用途別(政府機関、TPA、健康保険)、地域別予測Global Health Insurance Exchange (HIX) Market to reach USD XXX billion by 2025. Global Health Insurance Exchange (HIX) Market valued approximately USD XXX billion in 2016 is forecasted to grow with a healthy growth rate of more than XX% over the forecast period 2018-2025. The major factors speculated to augment the markets are increasing federal grants and emergence of private cloud-based architec …
- 結晶セルロース(MCC)の世界市場動向及び予測Microcrystalline cellulose (MCC) is used as binder, thickening agent, suspension agent, and bulking agent in a variety of application such as food & beverages, pharmaceutical, cosmetics & personal care, and others. This report on the global MCC market covers all major regions such as Asia-Pacific, Europe, North America, and Rest of the World. The report analyzes the market trends and provides fore …
- 包装用特殊高機能フィルムの世界市場2016-2020About the Specialty and High-Performance Packaging Film Market Specialty and high-performance films are thin films with unique features such as high or low heat conductivity, barrier properties, special surface properties, high purity, and mechanical properties. As a result of the unique properties, specialty and high-performance films are used to protect different products that are enclosed in th …
- L-(+)-Ergothioneineの世界市場L-(+)-Ergothioneine (CAS 58511-63-0) Market Research Report 2013 presents comprehensive data on l-(+)-ergothioneine markets globally and regionally (Europe, Asia, North America etc.) The L-(+)-Ergothioneine (CAS 58511-63-0) Market Research Report 2013 includes l-(+)-ergothioneine description, covers its application areas and related patterns. It overviews l-(+)-ergothioneine market, names l-(+)-er …
- 製造業におけるIoTの世界市場予測(~2021):ソフトウェア別(ネットワーク・アプリケーションセキュリティ、ネットワーク帯域幅、リモート監視、データ管理、スマートサーベイランス)、プラットフォーム別、サービス別、用途別、産業別、地域別“Growing need for centralized monitoring and predictive maintenance of manufacturing infrastructure is boosting the growth of the IoT in manufacturing market”The Internet of Things (IoT) in manufacturing market size is expected to grow USD 6.17 billion in 2016 to USD 20.59 billion by 2021, at a Compound Annual Growth Rate (CAGR) of 27.2% from 2016 to 2021. Predictive maintenance plays a significan …
- 自動車用ディスクブレーキ世界市場2015-2019About Automotive Disc Brake A brake system is a component that is used to reduce the speed of a vehicle. A disc brake is used to slow down or stop the rotation of a wheel using brake pads, brake callipers, and brake discs. Drum brakes use brake shoes to create friction and slow down or stop a vehicle, and disc brakes use brake pads for the same. Disc brakes are usually made of materials such as ca …
- 世界のホットドリンク市場動向:企業M&A(2014年5月)Synopsis The report provides a review of the mergers and acquisitions (M&As), partnering deals, and agreements entered into by companies active in the global hot drinks market during May 2014. Summary Using this report, dealmakers will effectively gain an insight into deal activity of the global hot drinks market throughout the month. Additionally, the report provides an overview of all the partne …
- 浸透膜発電の分析:Analyzing Osmotic PowerWith the threat of the global climate change looming large over our heads, more and more research has been ongoing into renewable energy. One such upcoming renewable energy is that of osmotic power. There are many unknown facts about this particular source of renewable energy. The mixing of freshwater and saltwater releases a large amount of energy. Harnessing this energy is the entire concept beh …
- 世界の商用航空機市場動向2013-2023:市場規模及び成長要因The global commercial aircraft sector is expected to experience slow and stable growth during the forecast period. According to Boeing’s estimates, airline companies around the world are expected to procure approximately 34000 airplanes during 2011-2031.
- LEDライトエンジンの世界市場展望2017-2026According to Stratistics MRC, the Global LED Light Engine Market is accounted for $21.88 billion in 2017 and is expected to reach $84.53 billion by 2026 growing at a CAGR of 16.2% during the forecast period. The increasing consumer demand for energy-efficient lighting systems, reduction in prices of LEDs, and high penetration of LEDs as a light source in the general lighting market are expected to …
- 使い捨て気道診断装置の世界市場2019-2023About this market Lung disorders such as lunh cancer, tuberculosis, and pneumonia can affect the airways and lungs. They are primarily caused by dust, microbial infection, air pollution, smoke from tobacco products, and occupational chemicals. Lung disorders impact the air sacs (alveoli), which can lead to pulmonary edema. In such cases, single-use airway diagnostic devices are used to examine the …
- 美容医療機器の世界市場:皮膚表面再生レーザー、脂肪吸引、セルライト低減、脂肪低減、皮膚引き締め、乳房インプラント、ボトックス、皮膚充填剤The global medical aesthetics market is estimated to grow at a CAGR of 10.8% from 2015 to 2020. North America held the largest share of the medical aesthetics market in 2015. However, the Asia-Pacific region is poised to grow at the highest CAGR of 12.6% in the next five years. Factors such as rising consumer awareness and interest in aesthetic procedures, strong local economies, aggressive market …
- 世界のトランスオイル(変圧器油)市場(~2018)This report estimates the transformer oil market in terms of volume and value. The volume market is estimated in terms of the demand of the transformer oil per year. The report estimates the market size of the transformer oil industry for product types such as mineral oil which is further classified into naphthenic and paraffinic; silicone, and bio-based transformer oils. This has been broken down …
- 世界の不揮発性メモリ(Non-Volatile Memory)市場動向2014 – 2020Non-volatile memory is used to store data even if it is non-powered. Non-volatile memory is used for secondary storage, especially long term storage, as these memory devices do not require continuous power supply for storing information. Because of this, the non-volatile memories are widely used in mission critical applications such as data centers. Although devices which can store information up …